Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Abvc Biopharma Inc
(NQ:
ABVC
)
0.7151
+0.0051 (+0.72%)
Streaming Delayed Price
Updated: 3:48 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Abvc Biopharma Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
70 Stocks Moving In Monday's Mid-Day Session
June 13, 2022
Gainers Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares jumped 110% to $13.93 after the company announced initial data from the pivotal FIREFLY-1 trial of tovorafenib in relapsed pediatric...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
June 13, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
June 13, 2022
Good morning, traders! We're starting off the week with a dive into the biggest pre-market stock movers for Monday morning!
Via
InvestorPlace
91 Biggest Movers From Friday
June 13, 2022
Gainers RISE Education Cayman Ltd (NYSE: REDU) shares jumped 138.5% to settle at $3.41 on Friday. RISE Education announced expected timing for the completion of the merger with Dada Auto.
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
June 10, 2022
Gainers bluebird bio (NASDAQ:BLUE) shares rose 53.4% to $6.12 during Friday's after-market session. Trading volume for this security closed at 5.0 million, accounting for 206.3% of its average full-day...
Via
Benzinga
ABVC BioPharma Announces Termination of Two Contracts
June 10, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
Product Safety
ABVC BioPharma Announces Enrollment Progress for ADHD Phase II Part 2 Clinical Study
June 01, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ABVC BioPharma Engaged by Orion BioTech to Identify Global Licensing Partners
May 25, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
Product Safety
Prestigious Researchers to Provide Consulting Services in Connection with ABVC BioPharma's Depression Medicines
May 23, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ABVC Biopharma Reports First Quarter 2022 Financial and Operational Results
May 16, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
COVID-19
ABVC BioPharma Engages the FreeMind Group to Support Grant Funding
May 13, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
Product Safety
ABVC BioPharma, Inc. Announces $4.22 Million Registered Direct Offering
May 12, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
90 Biggest Movers From Yesterday
May 13, 2022
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) surged 70.5% to close at $0.1330 on Thursday after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered...
Via
Benzinga
58 Stocks Moving In Thursday's Mid-Day Session
May 12, 2022
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 102.6% to $0.1580 after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering.
Via
Benzinga
ABVC BioPharma ADHD Phase II Part 2 Clinical Study First Subject Treated
May 10, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ABVC BioPharma Announces Streamlined Vitargus(R) Manufacturing Process
May 05, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ABVC BioPharma Enters Into $3.0 Million Clinical Services Contract with NeuCen BioMed
May 03, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
Product Safety
ABVC BioPharma Completes Site Initiation Visits and Begins Enrollments for ADHD Phase II Part 2 Clinical Study
April 28, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ABVC BioPharma Announces Vitargus Phase II Clinical Study Investigator Meeting
April 26, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ABVC Biopharma Announces Fiscal Year 2021 Financial and Operational Results
March 31, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ABVC BioPharma to Present at the Maxim Group 2022 Virtual Growth Conference
March 23, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
87 Biggest Movers From Yesterday
March 10, 2022
Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares jumped 150% to close at $3.80 on Wednesday. Sunshine Biopharma, last month, priced its 1.88 million unit uplisting to...
Via
Benzinga
ABVC BioPharma Announces Principal Investigator Meeting for Phase II Part 2 ADHD Clinical Study
February 02, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
From Mobile Clinics to Drug Development, This Company Is Attempting to Tackle Brain Disorders and Promote Mental Health Advances
January 05, 2022
Photo by David Matos on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...
Via
Benzinga
ABVC BioPharma Selects Additional Vitargus Phase II Study Sites
January 05, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ABVC BioPharma's Vitreous Substitute Vitargus Presented at 14th APVRS Congress
December 22, 2021
Fremont, CA - (NewMediaWire) - December 22, 2021 - ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and...
Via
NewMediaWire
Mobile Clinics Featuring Novel Mental Health Treatments Reportedly Coming to Florida and Nevada
December 20, 2021
Photo by Insung Yoon on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...
Via
Benzinga
ABVC BioPharma Medical Device Vitargus Receives Taiwan National Innovation Award
December 15, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
This Biotech Company Specializing in Brain Disorder Treatments Reports a Stronger Cash Position
December 13, 2021
Photo by Hal Gatewood on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...
Via
Benzinga
Why ABVC BioPharma Shares Are Trading Higher On Friday?
December 10, 2021
ABVC BioPharma Inc (NASDAQ: ABVC) shares gained during the market trading session on continued momentum from yesterday's dietary supplement distribution deal and after a...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.